Evaluation of paradoxical TB-associated IRIS with the use of standardized case definitions for resource-limited settings

J Int Assoc Physicians AIDS Care (Chic). 2010 Mar-Apr;9(2):104-8. doi: 10.1177/1545109710361537. Epub 2010 Feb 16.

Abstract

Objective: Standardized case definitions have recently been proposed by the International Network for the Study of HIV-associated immune reconstitution inflammatory syndrome (INSHI; [IRIS]) for use in resource-limited settings. We evaluated paradoxical tuberculosis (TB)-associated IRIS in a large cohort from a TB endemic setting with the use of these case definitions.

Design: A retrospective cohort study.

Method: We reviewed records from 1250 South African patients who initiated antiretroviral therapy (ART) over a 5-year period.

Results: A total of 333 (27%) of the patients in the cohort had prevalent TB at the initiation of ART. Of 54 possible paradoxical TB-associated IRIS cases, 35 fulfilled the INSHI case definitions (11% of TB cases).

Conclusions: INSHI-standardized case definitions were used successfully in identifying paradoxical TB-associated IRIS in this cohort and resulted in a similar proportion of TB IRIS cases (11%) as that reported in previous studies from resource-limited settings (8%-13%). This case definition should be evaluated prospectively.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • AIDS-Related Opportunistic Infections / immunology
  • AIDS-Related Opportunistic Infections / microbiology
  • AIDS-Related Opportunistic Infections / physiopathology
  • Adult
  • Anti-HIV Agents / therapeutic use
  • CD4 Lymphocyte Count
  • Cohort Studies
  • Developing Countries*
  • Female
  • HIV Infections / complications
  • HIV Infections / drug therapy*
  • HIV Infections / immunology*
  • HIV-1
  • Humans
  • Immune Reconstitution Inflammatory Syndrome* / etiology
  • Immune Reconstitution Inflammatory Syndrome* / immunology
  • Immune Reconstitution Inflammatory Syndrome* / physiopathology
  • Male
  • Mycobacterium tuberculosis
  • Reference Standards
  • Retrospective Studies
  • South Africa
  • Tuberculosis / complications*
  • Tuberculosis / immunology
  • Tuberculosis / microbiology
  • Tuberculosis / physiopathology

Substances

  • Anti-HIV Agents